You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Nesiritide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for nesiritide and what is the scope of patent protection?

Nesiritide is the generic ingredient in one branded drug marketed by Scios Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for nesiritide.

Summary for nesiritide
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 2
Clinical Trials: 62
Patent Applications: 2,246
DailyMed Link:nesiritide at DailyMed
Recent Clinical Trials for nesiritide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Vanderbilt University Medical CenterPhase 3
AstraZenecaPhase 3
Vanderbilt University Medical CenterPhase 4

See all nesiritide clinical trials

US Patents and Regulatory Information for nesiritide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scios Llc NATRECOR nesiritide FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for nesiritide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Scios Llc NATRECOR nesiritide FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ⤷  Sign Up ⤷  Sign Up
Scios Llc NATRECOR nesiritide FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ⤷  Sign Up ⤷  Sign Up
Scios Llc NATRECOR nesiritide FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.